Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
CYTK holding history
Cytokinetics Inc in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings
- Shares (Q2 2026)
- 19,007
- Value
- $1.62M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 19,007 | $1.62M | <0.1% | +10,166+115.0% | Added | Holders |
| Q1 2026 | 8,841 | $582.7K | <0.1% | −384−4.2% | Reduced | Holders |
| Q4 2025 | 9,225 | $586.2K | <0.1% | +7,125+339.3% | Added | Holders |
| Q3 2025 | 2,100 | $115.4K | <0.1% | −1,641−43.9% | Reduced | Holders |
| Q2 2025 | 3,741 | $123.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,741 | $150.4K | <0.1% | −7,200−65.8% | Reduced | Holders |
| Q4 2024 | 10,941 | $514.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,941 | $577.7K | <0.1% | −5,718−34.3% | Reduced | Holders |
| Q2 2024 | 16,659 | $902.6K | <0.1% | +1,019+6.5% | Added | Holders |
| Q1 2024 | 15,640 | $1.10M | <0.1% | −3,260−17.2% | Reduced | Holders |
| Q4 2023 | 18,900 | $1.58M | <0.1% | −18,200−49.1% | Reduced | Holders |
| Q3 2023 | 37,100 | $1.09M | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 37,100 | $1.21M | <0.1% | −17,100−31.5% | Reduced | Holders |
| Q1 2023 | 54,200 | $1.91M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 54,200 | $2.48M | <0.1% | −17,000−23.9% | Reduced | Holders |
| Q3 2022 | 71,200 | $3.45M | <0.1% | +4,800+7.2% | Added | Holders |
| Q2 2022 | 66,400 | $2.61M | <0.1% | −2,600−3.8% | Reduced | Holders |
| Q1 2022 | 69,000 | $2.54M | <0.1% | +69,000 | New | Holders |